Novel mechanism of resistance to targeted therapies in lung cancer

被引:3
|
作者
Wang, Walter [1 ]
Carbone, David P. [1 ]
Arasada, Rajeswara Rao [1 ]
机构
[1] Ohio State Univ, Med Ctr, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
关键词
EGFR; Notch3; EGFR TKI; drug persister cells; cancer stem cells; PATHWAY; NOTCH;
D O I
10.1080/23723556.2018.1551015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have identified a non-canonical role of0 Notch3 in response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy, whereby Notch3 associates with beta-catenin, resulting in increased catenin beta-1 (CTNNB1, best known as beta-catenin) stability and increased survival of drug persister cells (DPCs). Furthermore, combined treatment of an EGFR TKI with a beta-catenin inhibitor demonstrated improved therapeutic outcomes in xenograft models.
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Resistance to Targeted Therapies in Lung Cancer
    Bivona, T.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 133 - 133
  • [2] Novel targeted therapies in lung cancer
    Salgia, Ravi
    TUMOR BIOLOGY, 2007, 28 : 28 - 28
  • [3] Resisting Resistance: Targeted Therapies in Lung Cancer
    Lin, Jessica J.
    Shaw, Alice T.
    TRENDS IN CANCER, 2016, 2 (07): : 350 - 364
  • [4] Evolution of Acquired Resistance to Targeted Therapies in Lung Cancer
    Hata, Aaron N.
    ONCOLOGIST, 2014, 19 : S4 - S4
  • [5] Targeted therapies in lung cancer
    Besse, B.
    Ropert, S.
    Soria, J. C.
    ANNALS OF ONCOLOGY, 2007, 18 : 135 - 142
  • [6] Targeted Therapies in Lung Cancer
    Pirker, Robert
    Filipits, Martin
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (02) : 188 - 206
  • [7] Targeted lung cancer therapies
    Farmer, G
    NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (07) : 547 - U7
  • [8] Targeted lung cancer therapies
    George Farmer
    Nature Reviews Drug Discovery, 2004, 3 : 547 - 548
  • [9] Immunotherapy and lung cancer: current developments and novel targeted therapies
    Domingues, Duarte
    Turner, Alice
    Silva, Maria Dilia
    Marques, Dania Sofia
    Mellidez, Juan Carlos
    Wannesson, Luciano
    Mountzios, Giannis
    de Mello, Ramon Andrade
    IMMUNOTHERAPY, 2014, 6 (11) : 1221 - 1235
  • [10] Targeted Therapies for Lung Cancer Clinical Experience and Novel Agents
    Larsen, Jill E.
    Cascone, Tina
    Gerber, David E.
    Heymach, John V.
    Minna, John D.
    CANCER JOURNAL, 2011, 17 (06): : 512 - 527